<!DOCTYPE html>
<html lang="tr">
<head>
<link rel="alternate" hreflang="tr" href="https://uzunyasa.com/pages/blog/aralikli-oructa-yag-kaybi-ve-kas-koruma-bilimsel-inceleme.html">
<link rel="alternate" hreflang="x-default" href="https://uzunyasa.com/pages/blog/aralikli-oructa-yag-kaybi-ve-kas-koruma-bilimsel-inceleme.html">
<meta http-equiv="Content-Language" content="tr">
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>AralÄ±klÄ± OruÃ§ta YaÄŸ KaybÄ± ve Kas Koruma: Bilimsel Ä°nceleme | UzunYaÅŸa Blog</title>
    <meta name="description" content="AralÄ±klÄ± orucun obezitede yaÄŸ ve kas dengesini nasÄ±l etkilediÄŸini araÅŸtÄ±ran bilimsel bulgular. Hyperinsulinemia ve IRF4'Ã¼n rolÃ¼.">
    <link rel="canonical" href="https://uzunyasa.com/pages/blog/aralikli-oructa-yag-kaybi-ve-kas-koruma-bilimsel-inceleme.html">
    <meta property="og:title" content="AralÄ±klÄ± OruÃ§ta YaÄŸ KaybÄ± ve Kas Koruma: Bilimsel Ä°nceleme">
    <meta property="og:description" content="AralÄ±klÄ± orucun obezitede yaÄŸ ve kas dengesini nasÄ±l etkilediÄŸini araÅŸtÄ±ran bilimsel bulgular. Hyperinsulinemia ve IRF4'Ã¼n rolÃ¼.">
    <meta property="og:image" content="https://images.unsplash.com/photo-1571019613454-1cb2f99b2d8b?w=1200&h=600&fit=crop">
    <meta property="og:type" content="article">
    <meta property="og:url" content="https://uzunyasa.com/pages/blog/aralikli-oructa-yag-kaybi-ve-kas-koruma-bilimsel-inceleme.html">
    <meta property="og:site_name" content="UzunYaÅŸa">
    <meta property="article:published_time" content="2026-02-21">
    <meta property="article:section" content="Kilo YÃ¶netimi">
    <meta property="article:tag" content="aralÄ±klÄ± oruÃ§">
    <meta property="article:tag" content="obezite">
    <meta property="article:tag" content="insÃ¼lin">
    <meta property="article:tag" content="kas koruma">
    <meta property="article:tag" content="yaÄŸ kaybÄ±">
    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:title" content="AralÄ±klÄ± OruÃ§ta YaÄŸ KaybÄ± ve Kas Koruma: Bilimsel Ä°nceleme">
    <meta name="twitter:description" content="AralÄ±klÄ± orucun obezitede yaÄŸ ve kas dengesini nasÄ±l etkilediÄŸini araÅŸtÄ±ran bilimsel bulgular. Hyperinsulinemia ve IRF4'Ã¼n rolÃ¼.">
    <meta name="twitter:image" content="https://images.unsplash.com/photo-1571019613454-1cb2f99b2d8b?w=1200&h=600&fit=crop">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <!-- Google Analytics -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=G-QBM7E0EHFP"></script>
    <script>window.dataLayer=window.dataLayer||[];function gtag(){dataLayer.push(arguments);}gtag('js',new Date());gtag('config','G-QBM7E0EHFP');</script>
    <script type="application/ld+json">
    {
      "@context": "https://schema.org",
      "@type": "Article",
      "headline": "AralÄ±klÄ± OruÃ§ta YaÄŸ KaybÄ± ve Kas Koruma: Bilimsel Ä°nceleme",
      "description": "AralÄ±klÄ± orucun obezitede yaÄŸ ve kas dengesini nasÄ±l etkilediÄŸini araÅŸtÄ±ran bilimsel bulgular. Hyperinsulinemia ve IRF4'Ã¼n rolÃ¼.",
      "image": "https://images.unsplash.com/photo-1571019613454-1cb2f99b2d8b?w=1200&h=600&fit=crop",
      "datePublished": "2026-02-21",
      "author": {
        "@type": "Organization",
        "name": "UzunYaÅŸa",
        "url": "https://uzunyasa.com"
      },
      "publisher": {
        "@type": "Organization",
        "name": "UzunYaÅŸa",
        "logo": { "@type": "ImageObject", "url": "https://uzunyasa.com/images/logo.svg" }
      },
      "mainEntityOfPage": "https://uzunyasa.com/pages/blog/aralikli-oructa-yag-kaybi-ve-kas-koruma-bilimsel-inceleme.html"
    }
    </script>
    <style>
        :root {
            --primary: #195157;
            --accent: #E8963E;
            --text: #1a1a1a;
            --gray: #6b7280;
            --bg: #FAF9F7;
            --white: #FFFFFF;
            --border: #e5e7eb;
            --category-color: #F59E0B;
        }
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { font-family: 'Inter', sans-serif; color: var(--text); line-height: 1.8; background: var(--bg); }
        .header { position: fixed; top: 0; left: 0; right: 0; z-index: 1000; background: rgba(255,255,255,0.97); backdrop-filter: blur(10px); border-bottom: 1px solid var(--border); }
        .header-inner { max-width: 1200px; margin: 0 auto; padding: 0.75rem 2rem; display: flex; align-items: center; justify-content: space-between; }
        .logo-img { height: 60px; }
        .back-link { color: var(--primary); text-decoration: none; font-weight: 500; }
        .back-link:hover { text-decoration: underline; }
        article { max-width: 750px; margin: 0 auto; padding: 7rem 1.5rem 4rem; }
        .post-category { display: inline-block; background: #F59E0B20; color: #F59E0B; padding: 0.4rem 1rem; border-radius: 20px; font-size: 0.85rem; font-weight: 600; margin-bottom: 1rem; }
        h1 { font-size: 2.25rem; font-weight: 700; line-height: 1.3; margin-bottom: 1rem; }
        .post-meta { color: var(--gray); font-size: 0.9rem; display: flex; gap: 1rem; flex-wrap: wrap; margin-bottom: 2rem; }
        .featured-image { width: 100%; height: 350px; border-radius: 16px; overflow: hidden; margin-bottom: 2.5rem; }
        .featured-image img { width: 100%; height: 100%; object-fit: cover; }
        .post-content { font-size: 1.1rem; }
        .post-content h2 { font-size: 1.5rem; margin: 2.5rem 0 1rem; color: var(--primary); }
        .post-content h3 { font-size: 1.25rem; margin: 2rem 0 0.75rem; }
        .post-content p { margin-bottom: 1.25rem; }
        .post-content ul, .post-content ol { margin: 1rem 0 1.5rem 1.5rem; }
        .post-content li { margin-bottom: 0.5rem; }
        .post-content blockquote { border-left: 4px solid var(--accent); padding-left: 1.5rem; margin: 1.5rem 0; font-style: italic; color: var(--gray); }
        .post-content strong { color: var(--primary); }
        .key-points { background: var(--white); border: 2px solid var(--border); border-radius: 12px; padding: 1.5rem 1.5rem 1.5rem 2rem; margin: 2.5rem 0; }
        .key-points h4 { color: var(--primary); margin-bottom: 1rem; font-size: 1.1rem; }
        .key-points ul { margin: 0; }
        .key-points li { margin-bottom: 0.5rem; }
        .sources { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid var(--border); }
        .sources h4 { font-size: 1rem; margin-bottom: 0.75rem; color: var(--primary); }
        .sources ul { list-style: none; margin: 0; padding: 0; }
        .sources li { font-size: 0.9rem; color: var(--gray); margin-bottom: 0.5rem; }
        .sources a { color: var(--primary); }
        .disclaimer { background: #FEF3C7; border: 1px solid #F59E0B; border-radius: 8px; padding: 1rem; margin-top: 2rem; font-size: 0.9rem; color: #92400E; }
        .share-section { margin-top: 3rem; padding: 2rem; background: var(--white); border-radius: 12px; text-align: center; border: 1px solid var(--border); }
        .share-buttons { display: flex; gap: 0.75rem; justify-content: center; margin-top: 1rem; flex-wrap: wrap; }
        .share-btn { padding: 0.65rem 1.25rem; border-radius: 8px; text-decoration: none; font-weight: 500; font-size: 0.9rem; color: white; }
        .share-btn.twitter { background: #1DA1F2; }
        .share-btn.linkedin { background: #0A66C2; }
        .share-btn.whatsapp { background: #25D366; }
        .cta-section { margin-top: 3rem; padding: 2rem; background: linear-gradient(135deg, var(--primary), #2a6b73); border-radius: 12px; text-align: center; color: white; }
        .cta-section h3 { margin-bottom: 0.5rem; }
        .cta-section p { opacity: 0.9; margin-bottom: 1rem; }
        .cta-btn { display: inline-block; background: var(--accent); color: white; padding: 0.875rem 2rem; border-radius: 8px; text-decoration: none; font-weight: 600; }
        footer { background: var(--text); color: white; padding: 2rem; text-align: center; margin-top: 4rem; }
        footer p { opacity: 0.7; font-size: 0.9rem; }
        @media (max-width: 640px) { h1 { font-size: 1.65rem; } article { padding: 5.5rem 1rem 2rem; } .featured-image { height: 220px; } }
    </style>
</head>
<body>
    <header class="header">
        <div class="header-inner">
            <a href="../../index.html"><img src="../../images/logo.svg" alt="UzunYaÅŸa" class="logo-img"></a>
            <a href="../blog.html" class="back-link">â† Blog'a DÃ¶n</a>
        </div>
    </header>

    <article>
        <span class="post-category">âš–ï¸ Kilo YÃ¶netimi</span>
        <h1>AralÄ±klÄ± OruÃ§ta YaÄŸ KaybÄ± ve Kas Koruma: Bilimsel Ä°nceleme</h1>
        <div class="post-meta">
            <span>ğŸ“… 21 Åubat 2026</span>
            <span>â±ï¸ 10 dk okuma</span>
            <span>ğŸ“Š KanÄ±ta DayalÄ±</span>
        </div>

        <div class="featured-image">
            <img src="https://images.unsplash.com/photo-1571019613454-1cb2f99b2d8b?w=1200&h=600&fit=crop" alt="AralÄ±klÄ± OruÃ§ta YaÄŸ KaybÄ± ve Kas Koruma: Bilimsel Ä°nceleme" loading="lazy">
        </div>

        <div class="post-content">
            <h2>GiriÅŸ: AralÄ±klÄ± OruÃ§ ve VÃ¼cut Kompozisyonu</h2>

<p>AralÄ±klÄ± oruÃ§ (<a href="tip2-diyabet-zaman-kisitli-beslenme-intermittent-fasting.html" style="color:#0D7377; text-decoration:underline; text-decoration-color:rgba(13,115,119,0.3); text-underline-offset:2px;">intermittent fasting</a>), belirli zaman dilimlerinde kalori alÄ±mÄ±nÄ± kÄ±sÄ±tlayan bir beslenme yaklaÅŸÄ±mÄ±dÄ±r. Sistematik derlemeler, aralÄ±klÄ± orucun kilo kaybÄ±nda geleneksel kalori kÄ±sÄ±tlamasÄ±na benzer etkinlik gÃ¶sterdiÄŸini ortaya koymaktadÄ±r <sup>[2]</sup>. Ancak Ã¶nemli bir soru vardÄ±r: Bu sÃ¼reÃ§te kaybedilen aÄŸÄ±rlÄ±k yaÄŸdan mÄ±, yoksa kas kÃ¼tlesinden mi kaynaklanmaktadÄ±r?</p>

<p>TÃ¼rkiye'de yetiÅŸkin obezite oranÄ± OECD verilerine gÃ¶re yaklaÅŸÄ±k %30-35 aralÄ±ÄŸÄ±ndadÄ±r ve bu oran artmaya devam etmektedir. Bu baÄŸlamda, kilo verme stratejilerinin kas kÃ¼tlesini koruyup korumadÄ±ÄŸÄ± klinik aÃ§Ä±dan kritik bir sorudur â€” Ã¶zellikle yaÅŸlÄ±larda <a href="sarkopeni-tedavi-patofizyoloji-ve-guncel-yaklasimlar.html" style="color:#0D7377; text-decoration:underline; text-decoration-color:rgba(13,115,119,0.3); text-underline-offset:2px;">sarkopeni</a>k obezite riski nedeniyle.</p><h2>AraÅŸtÄ±rmanÄ±n Arka PlanÄ±</h2>

<p>AralÄ±klÄ± oruÃ§ genellikle 5:2 (haftada 2 gÃ¼n kalori kÄ±sÄ±tlamasÄ±) veya 16:8 (16 saat oruÃ§ penceresi) modelleriyle uygulanÄ±r. Meta-analizler, bu yÃ¶ntemin kalori kÄ±sÄ±tlamasÄ±yla benzer dÃ¼zeyde kilo kaybÄ± saÄŸladÄ±ÄŸÄ±nÄ±, ancak vÃ¼cut kompozisyonu Ã¼zerindeki etkilerinin tartÄ±ÅŸmalÄ± olduÄŸunu gÃ¶stermektedir <sup>[2,3]</sup>.</p>

<p>Marko DM ve arkadaÅŸlarÄ±nÄ±n 2026'da Cell Reports'ta yayÄ±nladÄ±ÄŸÄ± bir Ã§alÄ±ÅŸma, bu dengesizliÄŸin potansiyel bir mekanizmasÄ±nÄ± ortaya koymuÅŸtur: hiperinsulineminin adipositlerde IRF4 (Interferon Regulatory Factor 4) ekspresyonunu baskÄ±layarak yaÄŸ tutulumunu artÄ±rmasÄ± ve kas kÃ¼tlesi kaybÄ±nÄ± hÄ±zlandÄ±rmasÄ±.</p>

<p><strong>KanÄ±t dÃ¼zeyi: ğŸ”´ Hayvan deneyi</strong> â€” Bu bulgular aÄŸÄ±rlÄ±klÄ± olarak fare modellerine dayanmaktadÄ±r. Ä°nsanlara doÄŸrudan genelleÅŸtirilemez.</p><h3>AraÅŸtÄ±rmanÄ±n Ana BulgularÄ±</h3>

<p>Marko DM ve ekibinin Ã§alÄ±ÅŸmasÄ±nda, obez farelere 10 haftalÄ±k 5:2 aralÄ±klÄ± oruÃ§ uygulanmÄ±ÅŸtÄ±r. Temel bulgular:</p>

<ul>
<li><strong>Hiperinsulineminin etkisi:</strong> Kronik yÃ¼ksek insÃ¼lin seviyeleri olan farelerde yaÄŸ dokusu kÃ¼tlesi artarken kas kÃ¼tlesi azaldÄ±. Hiperinsulinemi, oruÃ§ dÃ¶nemlerinde bile besinlerin yaÄŸ dokusunda tutulmasÄ±na yol aÃ§tÄ±. <em>(KanÄ±t: fare modeli)</em></li>
<li><strong>IRF4'Ã¼n rolÃ¼:</strong> IRF4, adipositlerde insÃ¼line yanÄ±t veren bir transkripsiyon faktÃ¶rÃ¼dÃ¼r. YÃ¼ksek insÃ¼lin seviyeleri IRF4 ekspresyonunu baskÄ±ladÄ±. IRF4 nakavt farelerde kalori alÄ±mÄ± eÅŸit olmasÄ±na raÄŸmen yaÄŸ kÃ¼tlesi artarken kas kÃ¼tlesi azaldÄ± â€” bu da IRF4'Ã¼n besin partisyonunda anahtar rol oynadÄ±ÄŸÄ±nÄ± dÃ¼ÅŸÃ¼ndÃ¼rmektedir. <em>(KanÄ±t: fare modeli, gen nakavt)</em></li>
<li><strong>Ä°nsan gÃ¶zlemleri:</strong> Ã‡alÄ±ÅŸma, obez erkeklerde 48 saatlik oruÃ§ sonrasÄ± yÃ¼ksek bazal insÃ¼lin dÃ¼zeylerinin daha fazla yaÄŸsÄ±z kÃ¼tle kaybÄ±yla iliÅŸkili olduÄŸunu gÃ¶steren pilot veriler sunmuÅŸtur. <em>(KanÄ±t: kÃ¼Ã§Ã¼k Ã¶rneklemli gÃ¶zlemsel veri, doÄŸrulama gerekir)</em></li>
</ul>

<p>Bu bulgular, aralÄ±klÄ± orucun etkinliÄŸinin bireylerin metabolik profiliyle deÄŸiÅŸebileceÄŸini dÃ¼ÅŸÃ¼ndÃ¼rmektedir. Ã–zellikle <a href="insulin-direnci-belirtiler-tedavi.html" style="color:#0D7377; text-decoration:underline; text-decoration-color:rgba(13,115,119,0.3); text-underline-offset:2px;">insÃ¼lin direnci</a> olan bireylerde vÃ¼cut kompozisyonu sonuÃ§larÄ± farklÄ±lÄ±k gÃ¶sterebilir â€” ancak bu hipotezin bÃ¼yÃ¼k Ã¶lÃ§ekli insan Ã§alÄ±ÅŸmalarÄ±yla doÄŸrulanmasÄ± gerekmektedir.</p><h2>Klinik BaÄŸlam ve Yorum</h2>

<p>Bu fare Ã§alÄ±ÅŸmasÄ±nÄ±n sonuÃ§larÄ±nÄ± doÄŸrudan klinik pratiÄŸe uygulamak erken olsa da, aralÄ±klÄ± oruÃ§ ve kas koruma konusunda daha geniÅŸ bir literatÃ¼r mevcuttur:</p>

<ul>
<li>2021 tarihli bir sistematik derleme, aralÄ±klÄ± orucun sÃ¼rekli kalori kÄ±sÄ±tlamasÄ±na kÄ±yasla yaÄŸsÄ±z kÃ¼tle kaybÄ± aÃ§Ä±sÄ±ndan anlamlÄ± fark gÃ¶stermediÄŸini bildirmiÅŸtir <sup>[3]</sup></li>
<li>Bununla birlikte, yeterli protein alÄ±mÄ± (1.2-1.6 g/kg/gÃ¼n) ve <a href="sarkopeni-kas-kaybini-onlemek-icin-direnc-egzersizleri.html" style="color:#0D7377; text-decoration:underline; text-decoration-color:rgba(13,115,119,0.3); text-underline-offset:2px;">direnÃ§ egzersizi</a>, her tÃ¼rlÃ¼ kalori kÄ±sÄ±tlamasÄ± sÄ±rasÄ±nda kas koruma iÃ§in en gÃ¼Ã§lÃ¼ kanÄ±ta sahip stratejilerdir <sup>[4]</sup></li>
<li>Hiperinsulinemi ve insÃ¼lin direncinin kilo verme yanÄ±tÄ±nÄ± etkilediÄŸi gÃ¶zlemsel Ã§alÄ±ÅŸmalarda gÃ¶sterilmiÅŸtir; ancak IRF4 mekanizmasÄ±nÄ±n insanlardaki rolÃ¼ henÃ¼z doÄŸrulanmamÄ±ÅŸtÄ±r</li>
</ul>

<p>TÃ¼rkiye baÄŸlamÄ±nda, obezite prevalansÄ±nÄ±n yÃ¼ksekliÄŸi ve beslenme Ã¶rÃ¼ntÃ¼leri (yÃ¼ksek karbonhidrat aÄŸÄ±rlÄ±klÄ± diyet) gÃ¶z Ã¶nÃ¼nde bulundurulduÄŸunda, aralÄ±klÄ± oruÃ§ uygulayan bireylerin protein alÄ±mÄ±na ve fiziksel aktiviteye Ã¶zel dikkat gÃ¶stermesi Ã¶nemlidir.</p><h2>Pratik Ã–neriler</h2>

<p>AÅŸaÄŸÄ±daki Ã¶neriler, yukarÄ±daki tek Ã§alÄ±ÅŸmaya deÄŸil, <strong>aralÄ±klÄ± oruÃ§ ve kas koruma konusundaki genel literatÃ¼re</strong> dayanmaktadÄ±r <sup>[2,3,4]</sup>:</p>

<h3>Kas Koruma Stratejileri</h3>
<ul>
<li><strong>Yeterli protein alÄ±mÄ±:</strong> Kalori kÄ±sÄ±tlamasÄ± sÄ±rasÄ±nda gÃ¼nlÃ¼k 1.2-1.6 g/kg protein alÄ±mÄ± hedeflenmelidir. Pratikte 70 kg bir birey iÃ§in gÃ¼nde 84-112 g protein (yemek penceresi iÃ§inde daÄŸÄ±tÄ±lmÄ±ÅŸ) <sup>[4]</sup></li>
<li><strong>DirenÃ§ egzersizi:</strong> Haftada en az 2-3 gÃ¼n tÃ¼m bÃ¼yÃ¼k kas gruplarÄ±nÄ± Ã§alÄ±ÅŸtÄ±ran direnÃ§ antrenmanÄ±, kalori aÃ§Ä±ÄŸÄ± dÃ¶neminde kas korumanÄ±n en gÃ¼Ã§lÃ¼ kanÄ±tlÄ± stratejisidir <sup>[4]</sup></li>
<li><strong>LÃ¶sine-zengin protein kaynaklarÄ±:</strong> Her Ã¶ÄŸÃ¼nde 2.5-3 g lÃ¶sin iÃ§eren protein kaynaklarÄ± (yumurta, et, sÃ¼t Ã¼rÃ¼nleri, baklagiller) kas protein sentezini uyarÄ±r</li>
</ul>

<h3>Metabolik DeÄŸerlendirme</h3>
<ul>
<li><strong>AÃ§lÄ±k insÃ¼lin ve HOMA-IR:</strong> Ä°nsÃ¼lin direnci deÄŸerlendirmesi iÃ§in aÃ§lÄ±k insÃ¼lin ve glukoz Ã¶lÃ§Ã¼mÃ¼ yapÄ±labilir. HOMA-IR &gt;2.5 insÃ¼lin direnci lehine deÄŸerlendirilir</li>
<li><strong>Diyabet hastalarÄ±nda dikkat:</strong> Tip 2 diyabet tedavisi alanlar, aralÄ±klÄ± oruÃ§ sÄ±rasÄ±nda hipoglisemi riski taÅŸÄ±r â€” mutlaka endokrinolog gÃ¶zetiminde uygulanmalÄ±dÄ±r</li>
</ul>

<h3>AralÄ±klÄ± OruÃ§ Modelleri</h3>
<ul>
<li><strong>16:8 modeli:</strong> En yaygÄ±n uygulama, 16 saat oruÃ§ + 8 saat beslenme penceresi</li>
<li><strong>5:2 modeli:</strong> Haftada 2 gÃ¼n 500-600 kcal'e kÄ±sÄ±tlama; kÄ±sÄ±tlÄ± gÃ¼nlerde protein Ã¶ncelikli beslenme Ã¶nerilir</li>
<li>Her iki modelin de sÃ¼rekli kalori kÄ±sÄ±tlamasÄ±na karÅŸÄ± belirgin Ã¼stÃ¼nlÃ¼ÄŸÃ¼ gÃ¶sterilmemiÅŸtir <sup>[2]</sup></li>
</ul><h2>SonuÃ§</h2>

<p>Marko DM ve arkadaÅŸlarÄ±nÄ±n Ã§alÄ±ÅŸmasÄ±, hiperinsulineminin aralÄ±klÄ± oruÃ§ sÄ±rasÄ±nda vÃ¼cut kompozisyonunu olumsuz etkileyebileceÄŸine dair mekanistik bir hipotez sunmaktadÄ±r. IRF4'Ã¼n besin partisyonundaki rolÃ¼ ilgi Ã§ekici bir bulgudur, ancak <strong>bu sonuÃ§lar aÄŸÄ±rlÄ±klÄ± olarak fare modellerine dayanmakta</strong> ve insan Ã§alÄ±ÅŸmalarÄ±yla doÄŸrulanmasÄ± gerekmektedir.</p>

<p>Genel literatÃ¼r baÄŸlamÄ±nda, aralÄ±klÄ± oruÃ§ kilo yÃ¶netiminde etkili bir araÃ§ olabilir â€” ancak kas korumasÄ± iÃ§in <strong>yeterli protein alÄ±mÄ± (1.2-1.6 g/kg/gÃ¼n) ve dÃ¼zenli direnÃ§ egzersizi</strong> her tÃ¼rlÃ¼ kalori kÄ±sÄ±tlama stratejisinde temel gerekliliktir. Bireysel metabolik profil, tedavi yanÄ±tÄ±nÄ± etkileyebilir; bu nedenle kilo yÃ¶netimi programlarÄ± kiÅŸiselleÅŸtirilmelidir.</p>
        </div>

        <div class="key-points">
            <h4>ğŸ“Œ Ã–nemli Noktalar</h4>
            <ul><li>AralÄ±klÄ± oruÃ§ obezitede kilo kaybÄ± saÄŸlÄ±yor ama kas kaybÄ± riski var.</li>
<li>YÃ¼ksek insÃ¼lin seviyeleri yaÄŸ tutulumunu artÄ±rÄ±p kas kaybÄ±nÄ± tetikliyor.</li>
<li>IRF4 faktÃ¶rÃ¼, besin daÄŸÄ±lÄ±mÄ±nÄ± etkileyerek kas korumasÄ±nda Ã¶nemli rol oynuyor.</li>
<li>Uygulamadan Ã¶nce doktor danÄ±ÅŸÄ±mÄ± ve insÃ¼lin takibi ÅŸart.</li></ul>
        </div>

        <div class="disclaimer">
            âš ï¸ <strong>Ã–nemli:</strong> Bu iÃ§erik sadece bilgilendirme amaÃ§lÄ±dÄ±r ve tÄ±bbi tavsiye yerine geÃ§mez. Herhangi bir tedaviye baÅŸlamadan Ã¶nce mutlaka doktorunuza danÄ±ÅŸÄ±n.
        </div>

        <div class="sources">
            <h4>ğŸ“š Kaynaklar</h4>
            <ol style="font-size: 0.9rem; color: #6b7280; line-height: 1.8; padding-left: 1.5rem;">
<li><a href="https://doi.org/10.1016/j.celrep.2026.117023" target="_blank" rel="noopener">Marko DM et al. Hyperinsulinemia promotes nutrient partitioning favoring adiposity during intermittent fasting. <em>Cell Reports.</em> 2026.</a></li>
<li>de Cabo R, Mattson MP. Effects of Intermittent Fasting on Health, Aging, and Disease. <em>N Engl J Med.</em> 2019;381:2541-2551.</li>
<li>Cioffi I, et al. Intermittent versus continuous energy restriction on weight loss and cardiometabolic outcomes: a systematic review and meta-analysis. <em>J Transl Med.</em> 2018;16:371.</li>
<li>Hector AJ, Phillips SM. Protein Recommendations for Weight Loss in Elite Athletes: A Focus on Body Composition and Performance. <em>Int J Sport Nutr Exerc Metab.</em> 2018;28:170-177.</li>
</ol>
        </div>

        <div class="share-section">
            <p><strong>Bu yazÄ±yÄ± paylaÅŸÄ±n</strong></p>
            <div class="share-buttons">
                <a href="https://twitter.com/intent/tweet?text=Aral%C4%B1kl%C4%B1%20Oru%C3%A7ta%20Ya%C4%9F%20Kayb%C4%B1%20ve%20Kas%20Koruma%3A%20Bilimsel%20%C4%B0nceleme%20%7C%20UzunYa%C5%9Fa&url=https%3A%2F%2Fuzunyasa.com%2Fpages%2Fblog%2Faralikli-oructa-yag-kaybi-ve-kas-koruma-bilimsel-inceleme.html" class="share-btn twitter" target="_blank" rel="noopener">Twitter</a>
                <a href="https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fuzunyasa.com%2Fpages%2Fblog%2Faralikli-oructa-yag-kaybi-ve-kas-koruma-bilimsel-inceleme.html" class="share-btn linkedin" target="_blank" rel="noopener">LinkedIn</a>
                <a href="https://wa.me/?text=Aral%C4%B1kl%C4%B1%20Oru%C3%A7ta%20Ya%C4%9F%20Kayb%C4%B1%20ve%20Kas%20Koruma%3A%20Bilimsel%20%C4%B0nceleme%20https%3A%2F%2Fuzunyasa.com%2Fpages%2Fblog%2Faralikli-oructa-yag-kaybi-ve-kas-koruma-bilimsel-inceleme.html" class="share-btn whatsapp" target="_blank" rel="noopener">WhatsApp</a>
            </div>
        </div>

        

<!-- Ä°LGÄ°LÄ° YAZILAR - Auto-generated by internal-links.js -->
<div class="related-posts-section" style="margin-top:3rem; padding-top:2rem; border-top:2px solid #e5e7eb;">
  <div style="display:flex; align-items:center; gap:12px; margin-bottom:1.5rem;">
    <div style="width:4px; height:32px; background:linear-gradient(to bottom, #0D7377, #14919B); border-radius:2px;"></div>
    <h2 style="margin:0; font-family:'Playfair Display', serif; font-size:1.5rem; color:#195157;">Ä°lgili YazÄ±lar</h2>
  </div>
  <div style="display:flex; flex-wrap:wrap; gap:1rem;">

      <a href="ramazanda-glp1-kullananlar-icin-oruc-rehberi.html" class="related-post-card" style="text-decoration:none; color:inherit; display:block; background:#fff; border:1px solid #e5e7eb; border-radius:12px; padding:1.25rem; transition:all 0.2s ease; flex:1; min-width:250px;">
        <div style="display:flex; align-items:center; gap:8px; margin-bottom:0.75rem;">
          <span style="font-size:1.2rem;">ğŸ’Š</span>
          <span style="font-size:0.75rem; font-weight:600; color:#EC4899; text-transform:uppercase; letter-spacing:0.5px;">Tedavi</span>
        </div>
        <h4 style="font-size:0.95rem; font-weight:600; color:#195157; margin-bottom:0.5rem; line-height:1.4;">Ramazanda GLP-1 Kullananlar Ä°Ã§in OruÃ§ Rehberi</h4>
        <p style="font-size:0.85rem; color:#6B7280; line-height:1.5; margin:0;">GLP-1 ilaÃ§larÄ±yla Ramazan orucunu gÃ¼venle tutmanÄ±n bilimsel rehberi. Ä°laÃ§ zamanlamasÄ±, hipoglisemi Ã¶nlemi, protein hedefâ€¦</p>
      </a>

      <a href="tip2-diyabet-zaman-kisitli-beslenme-intermittent-fasting.html" class="related-post-card" style="text-decoration:none; color:inherit; display:block; background:#fff; border:1px solid #e5e7eb; border-radius:12px; padding:1.25rem; transition:all 0.2s ease; flex:1; min-width:250px;">
        <div style="display:flex; align-items:center; gap:8px; margin-bottom:0.75rem;">
          <span style="font-size:1.2rem;">ğŸ§¬</span>
          <span style="font-size:0.75rem; font-weight:600; color:#8B5CF6; text-transform:uppercase; letter-spacing:0.5px;">Bilim</span>
        </div>
        <h4 style="font-size:0.95rem; font-weight:600; color:#195157; margin-bottom:0.5rem; line-height:1.4;">Tip 2 Diyabet ve Zaman KÄ±sÄ±tlÄ± Beslenme (Intermittent Fasting): Ne Diyor Bilim?</h4>
        <p style="font-size:0.85rem; color:#6B7280; line-height:1.5; margin:0;">Zaman kÄ±sÄ±tlÄ± beslenme (intermittent fasting) Tip 2 Diyabet yÃ¶netiminde etkili mi? 7 RCT ve meta-analiz verisiyle PICO bâ€¦</p>
      </a>

      <a href="score2-kalp-krizi-risk-hesaplama.html" class="related-post-card" style="text-decoration:none; color:inherit; display:block; background:#fff; border:1px solid #e5e7eb; border-radius:12px; padding:1.25rem; transition:all 0.2s ease; flex:1; min-width:250px;">
        <div style="display:flex; align-items:center; gap:8px; margin-bottom:0.75rem;">
          <span style="font-size:1.2rem;">ğŸ§¬</span>
          <span style="font-size:0.75rem; font-weight:600; color:#8B5CF6; text-transform:uppercase; letter-spacing:0.5px;">Bilim</span>
        </div>
        <h4 style="font-size:0.95rem; font-weight:600; color:#195157; margin-bottom:0.5rem; line-height:1.4;">SCORE2 ile Kalp Krizi Riskinizi HesaplayÄ±n â€” TÃ¼rkiye Neden YÃ¼ksek Riskli?</h4>
        <p style="font-size:0.85rem; color:#6B7280; line-height:1.5; margin:0;">SCORE2 ile 10-yÄ±llÄ±k kalp krizi riskinizi hesaplayÄ±n. TÃ¼rkiye neden kardiyovaskÃ¼ler hastalÄ±k aÃ§Ä±sÄ±ndan yÃ¼ksek riskli bÃ¶lâ€¦</p>
      </a>
  </div>
  <style>
    .related-post-card:hover { transform:translateY(-2px); box-shadow:0 4px 12px rgba(0,0,0,0.1); border-color:#14919B !important; }
    @media(max-width:768px) { .related-post-card { min-width:100% !important; } }
  </style>
</div>
<!-- END Ä°LGÄ°LÄ° YAZILAR -->

<div class="cta-section">
            <h3>SaÄŸlÄ±ÄŸÄ±nÄ±zÄ± test edin</h3>
            <p>2 dakikada kiÅŸisel saÄŸlÄ±k deÄŸerlendirmenizi yapÄ±n</p>
            <a href="../test.html" class="cta-btn">Teste BaÅŸla â†’</a>
        </div>
    </article>

    <footer><p>Â© 2026 UzunYaÅŸa. TÃ¼m haklarÄ± saklÄ±dÄ±r.</p></footer>
<script src="/scripts/premium-animations.js" defer></script>
</body>
</html>